Dr. Ginsburg joined Prometheus Laboratories in May 2017. He has well over 20 years of commercial
medical laboratory, diagnostics, and biotechnology industry experience. Dr. Ginsburg has overall
responsibility for clinical strategy, and provides leadership and oversight for clinical operations and
medical and scientific affairs.
Prior to joining Prometheus Laboratories, he had served as Chief Medical Officer for both publicly traded
and privately held companies, including MDxHealth, Toma Biosciences, and Iris International, Inc.
Dr. Ginsburg was a founder of AlliedPath, a personalized medicine company with a state-of-the-art
molecular diagnostics laboratory, which he sold to Iris International in July 2010, where he stayed on as
Chief Medical Officer and Executive Vice President. He was concomitantly Chief Medical Officer and
President of Arista, a diagnostics development and clinical laboratory division of Iris International.
In 2014, Iris was acquired by Beckman Coulter, a subsidiary of Danaher Corporation.
Before founding AlliedPath, Dr. Ginsburg was Senior Medical Director at Gen-Probe (now Hologic), and
prior to that, served as a Medical Director at Quest Diagnostics.
Dr. Ginsburg earned his medical degree at the University of Pretoria School of Medicine, South Africa,
later specializing in clinical pathology at the University of Witwatersrand and the South African Institute
of Medical Research, with a subspecialty in microbiology and immunology.